A photo of Punam Malik.

Punam Malik, MD

  • Director, Cincinnati Comprehensive Sickle Cell Center
  • Program Leader, Hematology and Gene Therapy Program
  • Marjory J. Johnson Chair, Gene and Cell Therapy
  • Professor, UC Department of Pediatrics


MBBS: University of Delhi, New Delhi, India, 1985.

MD: University of Delhi, New Delhi, India, 1989.

MS: University of Maryland, Baltimore, MD, 1991.

Fellowship: Children's Hospital Los Angeles, University of Southern California, 1995.

Services and Specialties

Cancer and Blood Diseases, Sickle Cell and Hemoglobin Disorders

Research Areas

Experimental Hematology and Cancer Biology, Cancer and Blood Diseases, Hematology

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information


Generation of a tyrosine hydroxylase-2A-Cre knockin non-human primate model by homology-directed-repair-biased CRISPR genome editing. Yoshimatsu, S; Okahara, J; Yoshie, J; Igarashi, Y; Nakajima, R; Sanosaka, T; Qian, E; Sato, T; Kobayashi, H; Morimoto, S; et al. Cell Reports: Methods. 2023; 3:100590.

Strategies for precise gene edits in mammalian cells. Fichter, KM; Setayesh, T; Malik, P. Molecular Therapy-Nucleic Acids. 2023; 32:536-552.

CRISPR/Cas9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease. Neidemire-Colley, LM; Khanal, S; Braunreiter, KM; Snyder, KJ; Gao, Y; Kalyan, S; Kararoud, MN; Duszynsk, M; Chi, M; Malik, P; et al. Journal of immunology (Baltimore, Md. : 1950). 2023; 210:173.21.

Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI). Adair, JE; Androski, L; Bayigga, L; Bazira, D; Brandon, E; Dee, L; Deeks, S; Draz, M; Dubé, K; Dybul, M; et al. Gene Therapy (Basingstoke). 2023; 30:216-221.

Future Directions and Resource Needs for National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Research: A Report of an NHLBI Workshop. McDonald, CL; Qasba, P; Anderson, DG; Bao, G; Colvin, RA; Kohn, DB; Malik, P; Mitchell, MJ; Pu, WT; Rawlings, DJ; et al. Human Gene Therapy. 2023; 34:83-89.

Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1. Smith, RH; Bloomer, H; Fink, D; Keyvanfar, K; Nasimuzzaman, M; Sancheznieto, F; Dutta, R; Guenther Bui, K; Alvarado, LJ; Bauer, TR; et al. Human Gene Therapy. 2022; 33:1293-1304.

CRISPR/CAS9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease. Khanal, S; Neidemire-Colley, L; Braunreiter, KM; Snyder, K; Gao, Y; Kalyan, S; Naeimi Kararoudi, M; Duszynski, ME; Chi, M; Malik, P; et al. Blood. 2022; 140:10200-10201.

NRASQ61R mutation in human endothelial cells causes vascular malformations. Boscolo, E; Pastura, P; Schrenk, S; Goines, J; Kang, R; Pillis, D; Malik, P; Le Cras, TD. Angiogenesis. 2022; 25:331-342.

Differential CXCR4 expression on hematopoietic progenitor cells versus stem cells directs homing and engraftment. Felker, S; Shrestha, A; Bailey, J; Pillis, DM; Siniard, D; Malik, P. JCI insight. 2022; 7:e151847.

Successful use of veno-venous extracorporeal membrane oxygenation for acute chest syndrome in a child with sickle cell disease and SARS-CoV-2. Koh, W; Malik, P; Whitehead, J; Morales, DL S; Hayes, D. Pediatric Pulmonology. 2022; 57:1096-1099.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Overall Patient Rating